Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology
Lantheus wins U.S. FDA approval for Pylarify TruVu PSMA-PET imaging agent
By
AuntMinnie.com staff writers
The new formulation shares the same diagnostic properties as the original Pylarify but supports higher radioactive concentrations.
March 9, 2026
SIR updates practice guidelines for chronic pelvic pain in women
By
AuntMinnie.com staff writers
Up to one-third of women with chronic pelvic pain may have a venous etiology.
March 6, 2026
ECR: Lessons from ACR's improvement initiative on prostate MRI quality
By
Kate Madden Yee
Prostate MRI is an essential tool for prostate cancer workup and management, but its image quality can be highly variable.
March 4, 2026
Prostate Cancer Foundation names 2025 Challenge Award recipients
By
AuntMinnie.com staff writers
The Prostate Cancer Foundation will award more than $12 million to 12 multi-institutional research teams.
March 3, 2026
Ablation as effective as surgery for treating small kidney cancers
By
Kate Madden Yee
In patients with stage T1a kidney cancer, ablation shows comparable progression risk but fewer complications.
March 3, 2026
CEUS outshines color Doppler imaging for indeterminate kidney lesions
By
Amerigo Allegretto
CEUS outperformed color Doppler ultrasound in a study focusing on indeterminate kidney lesions.
February 13, 2026
Clinicians, beware: CT diagnostic accuracy varies by adnexal lesion type
By
Kate Madden Yee
The modality correctly diagnoses dermoids and simple cysts, but is not as effective at identifying other types of adnexal lesions.
February 11, 2026
Elekta secures U.S. FDA 510(k) clearance for Evo
By
AuntMinnie.com staff writers
The company is moving forward with Elekta Evo CT-Linac.
January 16, 2026
Alliance for Clinical Trials in Oncology launches prostate cancer trial
By
AuntMinnie.com staff writers
The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.
January 5, 2026
LLMs help automate PI-RADS classification from MRI reports
By
Kate Madden Yee
The study findings could translate to better patient care, as correct classification of prostate lesions is key to treatment.
January 5, 2026
Transarterial embolization, cryoablation treat larger renal masses
By
Amerigo Allegretto
Sequential transarterial embolization and CT-guided percutaneous cryoablation can successfully treat renal masses.
December 22, 2025
Machine learning produces personalized risk estimates for prostate MRI
By
Kate Madden Yee
Machine learning offers risk estimates of abnormal prostate MRI and can support triage of this test, researchers noted.
November 6, 2025
Page 1 of 94
Next Page